Actin Depolymerization Disrupts Tight Junctions via Caveolae-mediated Endocytosis<sup><a href="#fn1" rid="fn1" class=" fn">V⃞</a></sup>
Abstract
The tight junction (TJ) determines epithelial barrier function. Actin depolymerization disrupts TJ structure and barrier function, but the mechanisms of this effect remain poorly understood. The goal of this study was to define these mechanisms. Madin-Darby canine kidney (MDCK) cells expressing enhanced green fluorescent protein-, enhanced yellow fluorescent protein-, or monomeric red fluorescent protein 1-fusion proteins of β-actin, occludin, claudin-1, ZO-1, clathrin light chain A1, and caveolin-1 were imaged by time-lapse multidimensional fluorescence microscopy with simultaneous measurement of transepithelial electrical resistance (TER). Actin depolymerization was induced with latrunculin A (LatA). Within minutes of LatA addition TER began to fall. This coincided with occludin redistribution and internalization. In contrast, ZO-1 and claudin-1 redistribution occurred well after maximal TER loss. Occludin internalization and TER loss, but not actin depolymerization, were blocked at 14°C, suggesting that membrane traffic is required for both events. Inhibition of membrane traffic with 0.4 M sucrose also blocked occludin internalization and TER loss. Internalized occludin colocalized with caveolin-1 and dynamin II, but not with clathrin, and internalization was blocked by dominant negative dynamin II (K44A), but not by Eps15Δ95-295 expression. Inhibition of caveolae-mediated endocytosis by cholesterol extraction prevented both LatA-induced TER loss and occludin internalization. Thus, LatA-induced actin depolymerization causes TJ structural and functional disruption by mechanisms that include caveolae-mediated endocytosis of TJ components.
Acknowledgments
We are indebted to Drs. James Anderson, Robert Campbell, Marcus Clark, Alan Fanning, Benjamin Glick, Tom Kirchhausen, Jennifer Lippincott-Schwartz, Randall Mrsny, Clive Palfrey, and Roger Tsien for generously sharing advice and essential reagents. This work was supported by the National Institutes of Health Grants R01DK061931 and R01DK068271, the Crohn's & Colitis Foundation of America, The University of Chicago Digestive Disease Center Grant P30 DK42086, and The University of Chicago Cancer Center Grant P30 CA14599.
Notes
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E04–12–1089) on June 15, 2005.
Abbreviations used: BS, bis(sulfosuccinimidyl)suberate; EGFP, enhanced green fluorescent protein; HBSS, Hank's balanced saline solution; LatA, latrunculin A; MBCD, methyl-β-cyclodextrin; MDCK, Madin-Darby canine kidney; mRFP1, monomeric red fluorescent protein 1; TER, transepithelial resistance; TJ, tight junction.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).










